Beng H Chong

Employment

• NSW Health Pathology Clinical Director/Senior Staff Specialist
  2012 - Present
• UNSW Sydney

Education

• University of New South Wales PhD
  1981 - 1983

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Disrupting HIT immune complexes as a new treatment for HIT
  Blood 2025 DOI: 10.1182/blood.2025029232
  +Save
• Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments
  Blood Advances 2024 DOI: 10.1182/bloodadvances.2024013883
  +Save
• NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
  Nature Communications 2022 DOI: 10.1038/s41467-022-32946-1
  +Save
• Inhibition of NADPH oxidase blocks NETosis and reduces thrombosis in heparin-induced thrombocytopenia
  Blood Advances 2021 DOI: 10.1182/bloodadvances.2020003093
  +Save
• Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses
  Blood Advances 2020 DOI: 10.1182/bloodadvances.2020002963
  +Save
• Evolving concepts of pathogenesis of heparin‐induced thrombocytopenia: Diagnostic and therapeutic implications
  International Journal of Laboratory Hematology 2020 DOI: 10.1111/ijlh.13223
  +Save
• Updated international consensus report on the investigation and management of primary immune thrombocytopenia
  Blood Advances 2019 DOI: 10.1182/bloodadvances.2019000812
  +Save
• Expression and functional roles of estrogen receptor GPR30 in human intervertebral disc
  The Journal of Steroid Biochemistry and Molecular Biology 2016 DOI: 10.1016/j.jsbmb.2016.01.012
  +Save
• NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
  DOI: 10.21203/rs.3.rs-753825/v1
  +Save